• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Crescent Moore Outlines Part D Changes to Expect in 2020

Video

Crescent Moore, PharmD, PhD, BCPS, senior consultant, BluePeak Advisors, discusses changes to Medicare Part D expected to come in 2020 and their implications.

Crescent Moore, PharmD, PhD, BCPS, senior consultant, BluePeak Advisors, discusses changes to Medicare Part D expected to come in 2020 and their implications.

Transcript

What changes to Medicare Part D should we expect to see in the coming year, and what will their implications likely be?

For 2020, I definitely think we’ll continue to see plan sponsors continue their opioid efforts as it is a top priority not only for CMS but also for the administration. Additionally, I think we’re going to see more plans move into administering the Part B step therapy, especially since for 2019, the memo came out a little late in the year for plans to really be able to jump on it quickly, and additionally with us having some more guidance coming this year, I think plans will definitely be ready for it for 2020. Indication-based formularies, I think it it’s not necessarily going to be a big, widespread adoption. I think we’re going to see plan sponsors maybe pilot it in a few therapeutic areas to really just see how it goes, how hard or how easy it is to administer, but at the end of the day, I think what we’re all trying to move towards and what we’re really hoping to see is some lower drug costs and better outcomes for our members.

Related Videos
Shawn Kwatra, MD, dermatologist, John Hopkins University
Dr Laura Ferris Discusses Safety, Efficacy of JNJ-2113 in Patients with Plaque Psoriasis
dr krystyn van vliet
Martin Dahl, PhD, senior vice president, AnaptysBio
Jeff Stark, MD, vice president, head of medical immunology, UCB.
Jonathan Silverberg, MD, PhD, MPH, FAAD, professor of dermatology, director of clinical research and patch testing, George Washington University School of Medicine and Health Sciences
Monica Li, MD, University of British Columbia
Robert Sidbury, MD, MPH, FAAD, professor of pediatrics, division head of dermatology, Seattle Children's Hospital, University of Washington School of Medicine
Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.